Phase 1Completed

Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)

A Phase 1 Open-Label Study to Evaluate the Interaction Potential Between AT 527 and Midazolam in Healthy Adult Subjects

Sponsor

Atea Pharmaceuticals, Inc. (Industry)

Enrollment

24 enrolled

Conditions

Healthy Volunteer Study

Interventions

AT-527 550 mg + midazolam; AT-527 550 mg + midazolam

Ages

adults, older adults

Registry

NCT04865445

Full record on ClinicalTrials.gov